dr. (Isaac) I. Corro Ramos MSc
(external) researcher Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Erasmus University Rotterdam
- Room
- J 8-27
- Telephone
- +31 10 4081829
- corroramos@imta.eur.nl
‹ Back to overview
Isaac Corro Ramos was born in Sevilla, Spain, on March 24th, 1977. He obtained his Master’s degree in Mathematics (option Statistics and Operations Research) from the University of Sevilla in June 2001. Between June 2001 and July 2005 Isaac had several jobs in different working areas and countries. He worked as a high-school Mathematics teacher in Sevilla (Spain), as a software programmer in Madrid (Spain) and Vienna (Austria), and as a researcher in Rome (Italy). In July 2005 he started his Ph.D. at the Department of Mathematics and Computer Science of the Eindhoven University of Technology working on the STRESS (Statistical Testing and Reliability Estimation of Software Systems) project. He defended his thesis on December 15, 2009.
Since August 2009 Isaac works as a scientific researcher at the Institute for Medical Technology Assessment (iMTA) in Rotterdam, The Netherlands. Since he enrolled iMTA he has worked in several research projects whose subjects include probabilistic modelling, cost-effectiveness analysis of health care technologies, value of information analysis and discrete event simulation.
- M.G. Franken, I. Corro Ramos, J. Los & M.J. Al (2018). The increasing importance of a continence nurse specialist to improve outcomes and save costs of urinary incontinence care: an analysis of future policy scenarios. BMC Family Practice, 19 (31). doi: DOI 10.1186/s12875-018-0714-9[go to publisher's site]
- M. Westwood, S. Lang, N. Armstrong, S. van Turenhout, J. Cubiella, L. Stirk, I. Corro Ramos, M. Luyendijk, R. Zaim, J. Kleijnen & C.G. Fraser (2017). Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Medicine, 15:189. doi: 10.1186/s12916-017-0944-z
- I. Corro Ramos, G.A.K. van Voorn, P. Vemer, T. Feenstra & M.J. Al (2017). A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data. Value in Health, 20 (8), 1041-1047. doi: 10.1016/j.jval.2017.04.016
- I. Corro Ramos, M.M. Versteegh, J.M. Koenders, G.C. Linssen, J. Meeder & M.P.M.H. Rutten - van Molken (2017). Cost-Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines. Value in Health. doi: https://doi.org/10.1016/j.jval.2017.05.013
- R. Riemsma, I. Corro Ramos, R. Birnie, N.C. Buyukkaramikli, N. Armstrong, S. Ryder, S. Duffy, G. Worthy, M.J. Al, J.L. Severens & J. Kleijnen (2016). Integrated sensor-augmented pump therapy system [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Health Technology Assessment, 20 (17). doi: http://dx.doi.org/10.3310/hta20170[go to publisher's site]
- G.A.K. van Voorn, P. Vemer, D. Hamerlijnck, I. Corro Ramos, G.J. Teunissen, M. Al & T.L. Feenstra (2016). The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling. Applied Health Economics and Health Policy, 14 (2), 129-133. doi: http://dx.doi.org/10.1007/s40258-015-0200-7[go to publisher's site]
- I. Corro Ramos, S. Lhachimi, A. Gerber-Grote & M.J. Al (2016). Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework. Medical Decision Making. doi: 10.1177/0272989X16636856[go to publisher's site]
- J. Bindels, B. Ramaekers, I. Corro Ramos, L. Mohseninejad, S. Knies, J. Grutters, M. Postma, M.J. Al, T. Feenstra & M. Joore (2016). Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives. Pharmacoeconomics (Print), 34 (3), 315-322. doi: http://dx.doi.org/10.1007/s40273-015-0346-z[go to publisher's site]
- P. Vemer, I. Corro Ramos, G.A.K. van Voorn, M.J. Al & T. Feenstra (2016). AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users. Pharmacoeconomics (Print), 34 (4), 349-361. doi: 10.1007/s40273-015-0327-2[go to publisher's site]
- V. Ignatyeva, J.L. Severens, I. Corro Ramos, G.R. Galstyan & M.V. Avxentyeva (2015). Costs of Hospital Stay in Specialized Diabetic Foot Department in Russia. Value in Health Regional Issues, 7C, 80-86. doi: http://dx.doi.org/10.1016/j.vhri.2015.09.003[go to publisher's site]
- O. Mandrik, I. Corro Ramos, S. Knies, M.J. Al & J.L. Severens (2015). Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine. Cancer Management and Research (online), 2015 (7), 279-289. doi: 10.2147/CMAR.S79258[go to publisher's site]
- I. Corro Ramos, M.P.M.H. Rutten - van Molken & M.J. Al (2015). Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis. Value in Health, 18 (1), 100-109. doi: 10.1016/j.jval.2014.09.003.
- P. Vemer, P.F.M. Krabbe, T.L. Feenstra, G.A.K. van Voorn, I. Corro Ramos & M.J. Al (2013). Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force. Value in Health, 16, 1106-1107. doi: http://dx.doi.org/10.1016/j.jval.2013.06.015[go to publisher's site]
- I. Corro Ramos, M.P.M.H. Rutten - van Molken & M.J. Al (2013). The role of value-of-information analysis in a health care research priority setting: a theoretical case study. Medical Decision Making, 33 (4), 472-489. doi: 10.1177/0272989X12468616
- I. Corro Ramos, M.P.M.H. Rutten - van Molken & M.J. Al (2012). The Role of Value-of-Information Analysis in a Health Care Research Priority Setting: A Theoretical Case Study. Medical Decision Making. doi: http://dx.doi.org/10.1177/0272989X12468616
- O. Mandrik, I. Corro Ramos, O. Zalis'ka, A. Gaisenko & J.L. Severens (2013). Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine. Value in Health, 2, 205-209. doi: http://dx.doi.org/10.1016/j.vhri.2013.06.006[go to publisher's site]
- P. Whiting, M.J. Al, M. Westwood, I. Corro Ramos, S. Ryder, N. Armstrong, K. Misso, J. Ross, J.L. Severens & J. Kleijnen (2016). Viscoelastic point-of-care testing to assist with the diagnosis management and monitoring of haemostasis a systematic review and cost-effectiveness analysis. (Extern rapport, 19, no 58). : Health Technology Assessment
- R. Riemsma, M.J. Al, I. Corro Ramos, S.N. Deshpande, N. Armstrong, Y.C. Lee, S. Ryder, C. Noake, M. Krol, M. Oppe, J. Kleijnen & J.L. Severens (2013). SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. (Extern rapport). Southampton: National Institute for Health Research
(external) researcher
- University
- Erasmus University Rotterdam
- School
- Erasmus School of Health Policy & Management
- Department
- Health Technology Assessment (HTA)
- Country
- Nederland
- Telephone
- +31 10 4081829